Juan Frias
Direttore Tecnico/Scientifico/R&S presso BIOMEA FUSION, INC.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ramses Erdtmann | M | 60 | 7 anni | |
| Tom Butler | M | 43 | 7 anni | |
| William Hait | M | 74 | 17 anni | |
| Michael Hitchcock | M | 74 | 3 anni | |
| Naomi Cretcher | F | - | 17 anni | |
| Franco Valle | M | 43 | 3 anni | |
| Steve Morris | M | - | 4 anni | |
| David Walton | M | - |
T1D Exchange
 T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | 6 anni |
| Peter Fasolo | M | 61 | 18 anni | |
| Elizabeth Faust | M | 59 | 2 anni | |
| Eric Aguiar | M | 62 | 4 anni | |
| Bihua Chen | F | 55 | 4 anni | |
| Anne Mulcahy | F | 70 | 15 anni | |
| Sumita Ray | F | 50 | 3 anni | |
| Alex Cacovean | M | - | 3 anni | |
| Nicole Rioles | F | - |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | - |
| Priyanka Mandava | F | - | - | |
| Hanna Cho | M | - | - | |
| Terrie Phan | F | - | 3 anni | |
| Anthony Souza | M | - | 9 anni | |
| Richard Altinger | M | - |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | 4 anni |
| Thorsten Kirschberg | M | 54 | 4 anni | |
| Rebecca Parkes | F | - |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | - |
| Henry Anhalt | M | - |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | 9 anni |
| Jack Collins | M | - |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | 6 anni |
| Heow Tan | M | 65 | 4 anni | |
| Abbie Celniker | M | 65 |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | - |
| John Brooks | M | 73 |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | 4 anni |
| Chun Yi Zhao | M | - | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Matthew Stuckley | M | - | 14 anni | |
| Joseph Scodari | M | 71 | 9 anni | |
| John Johnson | M | 66 | 19 anni | |
| Christophe Soulier | M | - | 5 anni | |
| Ian Davis | M | 73 | 13 anni | |
| Bryan Pinciaro | M | - | 1 anni | |
| Curtis Selquist | M | 79 | 36 anni | |
| Sarah L. Colamarino | F | - | 13 anni | |
| Robert J. Darretta | M | 78 | 39 anni | |
| William Perez | M | 76 | 13 anni | |
| Christine Poon | F | 71 | 9 anni | |
| Rosemary Crane | F | 64 | 6 anni | |
| Suneel Gupta | M | 66 | 6 anni | |
| Jabulani Mahange | M | 63 | 4 anni | |
| Greg Harriman | M | - | 10 anni | |
| Yves Decadt | M | 57 | 5 anni | |
| Thomas Hoy | M | 62 | - | |
| Torbjörn Sköld | M | 47 | 16 anni | |
| Lisa J. Uthgenannt | F | 63 | 10 anni | |
| Jeffrey R. Blom | M | 68 | 10 anni | |
| Brendan Weber | M | - | 2 anni | |
| Joseph Blechl | M | - | 2 anni | |
| Ravi Kiron | M | 64 | 3 anni | |
| Tracy Campbell Accardi | F | 64 | 4 anni | |
| Brian Imszennik | M | - | 6 anni | |
| Joe Volpe | M | - | 2 anni | |
| Mohan Nathan | M | - | 3 anni | |
| Jennifer Randall | F | - | - | |
| Ben Bowersox | M | - | 3 anni | |
| Natasha Kehimkar | F | - | 2 anni | |
| Elizabeth Anderson | F | 66 | 12 anni | |
| Julie McHugh | F | 59 | 2 anni | |
| Kim Rodriguez | F | - | 2 anni | |
| Steven Valentino | M | - | 7 anni | |
| Sheri Dodd | F | 58 | 13 anni | |
| Edwin Tucker | M | 52 | 3 anni | |
| David Pass | M | 56 | 6 anni | |
| Olu Fajemirokun-Beck | F | 58 | 2 anni | |
| Michael J. Dormer | M | 73 | 31 anni | |
| Ken Berlin | M | 59 | 13 anni | |
| Cameron Durrant | M | 63 | 2 anni | |
| Robert Michael Savel | M | 56 | 8 anni | |
| Kathleen Widmer | F | 62 | - | |
| Lynda M. Wallace | F | 61 | 9 anni | |
| Marc Robinson | M | 63 | 4 anni | |
| Peter Pfreundschuh | M | 55 | 8 anni | |
| Tai Ching Ho | M | 62 | 2 anni | |
| Philippe Schaison | M | 62 | 6 anni | |
| Arnold G. Langbo | M | 86 | 19 anni | |
| Steven Reinemund | M | 75 | 5 anni | |
| Ann Dibble Jordan | F | 89 | 26 anni | |
| Sandra B. Lawrence | F | 74 | 2 anni | |
| Taylor J. Crouch | M | 64 |
National Research Institute
 National Research Institute BiotechnologyHealth Technology National Research Institute provides therapies for health care. The firm focuses on therapeutic areas that affect minorities such as obesity, diabetes, hypertension, vaccines, dyslipidemias, hepatitis C, and osteoporosis, among others. It offers access to therapies through clinical research. The company was founded in 1981 and is headquartered in Los Angeles, CA. | 5 anni |
| Per A. Peterson | M | 79 | 13 anni | |
| Bridgette Heller | F | 62 | 5 anni | |
| Chao C. Chen | M | 70 | 25 anni | |
| Melanie Barstad | F | 71 | - | |
| Craig Fraser | M | 59 | 4 anni | |
| Jerett Creed | M | 50 | 1 anni | |
| James E. Goldschmidt | M | - | - | |
| Angela Ogden | M | - | 3 anni | |
| Shawn Bevec | M | - | 1 anni | |
| John R. Tushar | M | 62 | 6 anni | |
| Sean Cao | M | - | 3 anni | |
| Robert O’Holla | M | 72 | 18 anni | |
| Ajit Shetty | M | 77 | 5 anni | |
| Daphne Jones | F | 67 | 12 anni | |
| Koen Hasaers | M | 59 | 5 anni | |
| Kaye Foster-Cheek | F | 64 | 7 anni | |
| Kristine Peterson | F | 64 | 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 99 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Juan Frias
- Contatti personali